Contract 1410971

The contract award 1410971 was issued by the Department of Veterans Affairs to McKesson Drug Company, headquartered in Dallas, TX, for pharmaceutical services in Nebraska. The contract was awarded on January 8, 2026, with an extended performance period through January 1, 2099, indicating a long-term strategic procurement arrangement.

The contract is valued at $5,500.44 annually, with a contract type designated as ZO, which typically indicates a specific operational or supply-based agreement. While precise details of the products or services are not explicitly stated, McKesson's historical role as a major pharmaceutical distributor suggests this may involve medical supply, drug distribution, or healthcare product procurement for Veterans Affairs facilities within Nebraska. The extended performance timeline and relatively modest annual value suggest a targeted, potentially specialized service or supply arrangement.